James Del Rosso, DO: JCAD November 2025 Issue Highlights

Extended-cut Podcast—James Del Rosso, DO, and David G. Cotter, MD, PhD: Targeting the IL-31 Neuroimmune Pathway for Treating Prurigo Nodularis

James Del Rosso, DO: JCAD October 2025 Issue Highlights

David G. Cotter, MD, PhD: The Ideal Patient Candidate for Deuruxolitinib for Patients with Alopecia Areata

David G. Cotter, MD, PhD: Utilizing the 31-gene Expression Profile Test in Patients with Melanoma

James Del Rosso, DO: JCAD September 2025 Issue Highlights

David G. Cotter, MD, PhD: Providing Regrowth of Hair in Patients with Alopecia Areata

James Del Rosso, DO: JCAD August 2025 Issue Highlights

JCAD Dialogues and Reviews: Updates in Photoprotection and Recent Indication Expansions in Psoriasis and Rosacea

James Del Rosso, DO: JCAD June 2025 Issue Highlights

Extended-cut Podcast— Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis

James Del Rosso, DO: JCAD May 2025 Issue Highlights

James Del Rosso, DO: JCAD April 2025 Issue Highlights

James Del Rosso, DO: JCAD February 2025 Issue Highlights

JCAD Dialogues and Reviews: Highlighting a Vitiligo Roundtable Discussion in JCAD

JCAD Dialogues and Reviews: Considerations for Antibiotic Adverse Events

James Del Rosso, DO: JCAD January 2025 Issue Highlights

James Del Rosso, DO: Dermatology Year in Review 2024

JCAD Dialogues and Reviews: Spotlight on a Newly Approved Treatment for Rosacea

James Song, MD: Live from Elevate-Derm West—Why Older Immunosuppressant Agents are Still Relevant in 2024